O T C
PAOG Cannabis Pharmaceutical Research Initiative Gains New Traction

Sandusky, OH – September 30, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today indicated plans to reveal new information on the company’s initiative to expand its cannabis pharmaceutical treatment research beyond its current focus on Chronic Obstructive Pulmonary Disease (COPD). In a media interview scheduled for release on Friday, October

PAOG Target CBD Pharma Development In Puerto Rico Could Get Boost From COVID-19

Sandusky, OH – Sep 17, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today highlighted recent increased interest in the resurgence of industry-wide Pharmaceutical research and manufacturing in Puerto Rico. PAOG is currently in discussions in to engage a Contract Research Organization (CRO) in Puerto Rico to advance an Investigational New

PAOG Announces Agreement To Build Pharmaceutical Hemp Cultivar Facility On PURA Farmersville Site

Sandusky, OH – September 16, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced an agreement with Puration, Inc. (OTC PINK: PURA) to build a proprietary hemp cultivar development facility on PURA’s Farmersville, Texas branded site.    PAOG recently acquired a hemp cultivation business from PURA and is now expanding

PAOG Advances RespRx Research Into International CBD Pharma Research Arena

Sandusky, OH – Sep 15, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced an international research initiative to advance its hemp-derived cannabidiol (CBD) pharmaceutical treatment for Chronic Obstructive Pulmonary Disease (COPD). The COPD treatment, RespRx, is derived from a patented cannabis extraction method – U.S. Patent No. 9,199,960 entitled

PAOG Goes Global With CBD Pharmaceutical Research To Target $5.8 Billion Market

Sandusky, OH – Sep 15, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) Announces a multifold, international research initiative to advance its hemp-derived cannabidiol (CBD) pharmaceutical treatment for Chronic Obstructive Pulmonary Disease (COPD). The COPD treatment, RespRx, is derived from a patented cannabis extraction method – U.S. Patent No. 9,199,960 entitled

PAOG New Updates Toward Penetrating $5.8B Cannabis Pharmaceutical Market Coming This Friday

Sandusky, OH – Sep 14, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced an interview of CEO James C. DiPrima on MoneyTV with Donald Baillargeon scheduled for release this Friday, September 18, 2020.  DiPrima will discuss the company’s latest CBD bio pharma developments in addition to fielding questions on

PURA Announces Analyst Report Pertaining To Coming 1 For 1 Dividend

Dallas, TX – September 11, 2020 – OTC PR WIRE — Puration, Inc. (OTC PINK: PURA) today announced recent analyst research pertaining to the upcoming planned shareholder dividend for prompt distribution where shareholders are to receive one share of PAO Group, Inc. (OTC PINK: PAOG) for every PURA share held. Goldman Small Cap Research earlier this

DGDM Provides Further Analysis of Specific Trial Testing Results of Its Disruptive Pesticide Product Targeted at MJ Growers

FLOWER MOUND, TX, September 10, 2020 — OTC PR WIRE — Digital Development Partners, Inc. (OTC PINK: DGDM) (which will become Black Bird Potentials Inc.), exclusive distributor of MiteXstream biopesticide and manufacturer of Grizzly Creek Naturals CBD products, today provided further information relating to the results from ongoing pre-EPA certification in-field, private-party testing of its

PAOG Rated Bullish And Given PPS Target In Updated Analyst Report Published Today

Sandusky, OH – September 8, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced Goldman Small Cap Research has published an analyst research report update.  PAOG has recently entered the cannabis biopharmaceutical sector through two recent acquisitions.  The company acquired a cannabis cultivation business from Puration, Inc. (PURA). From Kali-Extracts

PAOG Announces Goldman Small Cap Research Update Scheduled Next Week

Sandusky, OH – September 2, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced an analyst research report update form Goldman Small Cap Research scheduled to be published next week on Tuesday, September 8, 2020. The original Goldman Small Cap Research Update can be reviewed at: Under The Radar CBD

Contact Us

  • 707-OTC-WIRE (707-682-9473)
  • cs@otcprwire.com

All Rights Reserved © 2019